Skip to main content
. 2023 Jun 5;30(6):5470–5484. doi: 10.3390/curroncol30060414

Table 2.

Surgical characteristics, histological type, and survival postoperative.

Variable Elderly
(n Patients, %)
Control
(n Patients, %)
p Value
Resektion Type p = 0.121
Pneumonectomy 36 (26.7%) 141 (37.6%)
Bilobectomy 8 (5.9%) 25 (6.7%)
Lobectomy 86 (63.7%) 198 (52.8%)
Segmentectomy 5 (3.7%) 11 (2.9%)
Tumor differentiation p = 0.014
High 17 (12.6%) 24 (6.4%)
Middle 67 (49.6%) 160 (42.7%)
Low 40 (29.6%) 163 (43.5%)
Undifferent 11 (8.1%) 28 (7.5%)
Tumor histology p = 0.037
SCC 80 (59.3%) 193 (51.5%)
Adenocarcinoma 34 (25.2%) 139 (37.1%)
Large cell carcinoma 14 (10.4%) 35 (9.3%)
other 7 (5.2%) 8 (2.1%)
Stage p = 0.002
I 75 (55.6%) 136 (36.6%)
II 30 (22.2%) 112 (29.9%)
III 26 (19.3%) 109 (29.1%)
IV 4 (3.0%) 18 (4.8%)
N-Status p = 0.002
N0–1 122 (90.4%) 294 (78.4%)
N2 13 (9.6%) 81 (21.6%)
30-day mortality 7 (5.2%) 10 (2.7%) p = 0.168
Survival p = 0.57
3-y-s 46% 48%
5-y-s 20.4% 25%
Mean (months) 43.469 45.298
Survival pro stage (mean survival in months)
Stage I 43.317 43.317 p = 0.5
Stage II 46.442 41.089 p = 0.6
Stage III 39.209 39.912 p = 0.6